LANSING – McLaren Health Care is investing another $150 million at a new fitness campus in Lansing.
The new investment, announced at a press convention on Thursday, raises the overall allocation budget to $600 million.
This makes the new campus the largest investment in the history of McLaren’s health system, for Kirk Ray, who runs McLaren Greater Lansing.
The campus is set on land purchased from the Michigan State University Foundation at its University Corporate Research Park, between Collins Road and US 127.
Ray’s new investment will go on to:
The campus will have the space of the new McLaren Orthopaedic Hospital, which will have 262 beds, according to new documents provided through the Michigan Department of Health and Human Services, 38 of them will come from McLaren Greater Lansing, which will have 73 beds., according to an updated exemption and a certificate of necessity.
McLaren described the new hospital, which replaces the existing orthopedic hospital on South Pennsylvania Avenue, as the “crown jewel of a comprehensive physical care campus.”
The campus will have a cancer center, the construction of a medical center and other amenities for the provision of health services, educational opportunities and medical research.
Much of Thursday’s press conference focused on the cancer center, whose structure the teams opened a few months ago, and which began entering metal beams at the end of July, according to a hospital spokesman.
Ray said he was looking for the new cancer center to be in position when his mother, who died of cancer in March, was fighting the disease.
“Our center will be a position of hope for healing and innovation,” he said.
A partnership with MSU that the new campus and cancer center will also be a “destination for resident doctors across the country,” Ray said.
Dr Norman Beauchamp agreed and said the new campus will recruit MSU academics and that the region will retain them as medical residents.
Dr. Amit Bhatt is pleased that the new cancer center is expanding local access to more than 800 clinical trials to be conducted through Karmanos and MSU.
Bhatt, a radiotherapist oncologist at the Karman Cancer Institute, said the new center will be an “intermediate piece of efforts to bring the most complex remedies to the region.”
The total effort is the biggest investment in Middle Michigan right now, Ray said.
“There are many advantages to that, ” he said.